Proteomic differences in hippocampus and cortex of sudden unexplained death in childhood

Dominique F Leitner1,2, Christopher William2,3, Arline Faustin2,3,4

  • 1Comprehensive Epilepsy Center, Department of Neurology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.

Acta Neuropathologica
|March 25, 2022
PubMed

Insights

Sudden unexplained death in childhood (SUDC) involves altered brain proteins, particularly in the frontal cortex and hippocampus. These proteomic changes may correlate with clinical factors, offering insights into SUDC pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Sudden unexplained death in childhood (SUDC) is a diagnosis of exclusion in children over one year of age.
  • SUDC shares clinical and pathological similarities with sudden unexpected death in epilepsy (SUDEP), suggesting potential common mechanisms involving the hippocampus and cortex.
  • Understanding the molecular underpinnings of SUDC is crucial for identifying potential causes and developing preventive strategies.

Purpose of the Study:

  • To investigate molecular signaling pathways and protein expression differences in the brains of children who died from SUDC compared to controls.
  • To identify specific brain regions and molecular pathways affected in SUDC.
  • To explore correlations between proteomic findings and clinical history in SUDC cases.

Main Methods:

  • Label-free quantitative mass spectrometry was employed on microdissected frontal cortex, hippocampus (dentate gyrus and CA1-3 regions).
  • Proteomic data from 19 SUDC cases and 19 age- and sex-matched pediatric controls were analyzed.
  • Pathway analysis and weighted gene correlation network analysis (WGCNA) were used to interpret differential protein expression and correlate findings with clinical data.

Main Results:

  • Significant differential protein expression was observed in all analyzed brain regions: 660 proteins in the frontal cortex, 170 in the dentate gyrus, and 57 in the CA1-3 region.
  • Key altered pathways included activated oxidative phosphorylation and inhibited EIF2 signaling in the frontal cortex, and activated acute phase response in the hippocampus.
  • Post-mortem virology and clinical history (fever, febrile seizures) showed significant correlations with specific molecular changes in brain tissue.

Conclusions:

  • Cortical and hippocampal proteomic alterations are present in SUDC cases.
  • These protein changes correlate with specific clinical features, suggesting a link between molecular pathology and clinical presentation.
  • Proteomic studies of SUDC cohorts are valuable for advancing the understanding of SUDC pathogenesis and may inform future preventive strategies.

Related Concept Videos